HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Looser Lip Balm Labeling Allowed Under Changes To FDA Rule

This article was originally published in The Rose Sheet

Executive Summary

Lip balms sold in small packages do not have to include a warning on their labeling to consult a doctor if user's condition does not clear up in seven days, according to an FDA final rule published Feb. 1 in the Federal Register

You may also be interested in...



Industry Groups Burned About Proposed Sunscreen Labeling Requirements

Sunscreen labeling that claims the product "helps prevent" premature skin aging, cancer and other damage does not suggest that sunscreen alone protects against these conditions, but in fact informs consumers that "complementary measures" are needed for adequate protection, trade groups say

Sunscreen Proposed Rule May Create UVA Protection Marketing Opportunity

FDA's proposed rule amending its final monograph on sunscreens to include UVA ray protection standards could create new marketing opportunities for manufacturers

Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations

The Skin Protectant Final Monograph covering products for minor cuts, scrapes, burns, chapped skin and lips, poison ivy, poison oak, poison sumac and insect bites allows for certain cross-monograph ingredient combinations, according to the rule published in the 1Federal Register June 4

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015216

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel